Induction of ovulation with pulsatile LHRH.

Area of Science:

• Reproductive Endocrinology
• Neuroendocrinology
• Infertility Treatment

Background:

• Hypogonadotropic amenorrhea results from hypothalamic or pituitary dysfunction, impacting reproductive hormone signaling.
• Luteinizing hormone-releasing hormone (LHRH) is crucial for regulating the reproductive axis.
• Pulsatile LHRH administration aims to mimic natural physiological secretion patterns.

Purpose of the Study:

• To evaluate the efficacy and safety of pulsatile intravenous LHRH administration in patients with hypogonadotropic amenorrhea.
• To assess the ovulatory response and pregnancy rates using this delivery method.
• To determine the tolerability and side effects associated with pulsatile LHRH therapy.

Main Methods:

• Seven patients with hypogonadotropic amenorrhea received intravenous LHRH via a pulsatile pump (Zyklomat-Ferring).
• Twenty-five treatment cycles were analyzed.
• Patient outcomes including ovulation, pregnancy, and adverse events were monitored.

Main Results:

• Eighteen out of 25 treatment cycles resulted in ovulation.
• Only one cycle was interrupted due to ovarian hyperstimulation.
• No adverse side effects were reported from the LHRH drug or the delivery system.

Conclusions:

• Pulsatile LHRH infusion is a safe and effective treatment for inducing ovulation in women with hypogonadotropic amenorrhea.
• The method shows a favorable safety profile with a low incidence of ovarian hyperstimulation and multiple pregnancies.
• This therapeutic approach represents a valid alternative to existing treatments for hypothalamic amenorrhea.